-
Product Insights
NewRecurrent Glioblastoma Multiforme (GBM) – Drugs In Development, 2024
Empower your strategies with our Recurrent Glioblastoma Multiforme (GBM) – Drugs In Development, 2024 report and make more profitable business decisions. Recurrent glioblastoma multiforme (GBM) refers to the return of aggressive brain tumors known as glioblastomas after initial treatment. GBM is the most malignant type of glioma, characterized by rapid growth and infiltrative behavior. Despite aggressive therapies like surgery, radiation, and chemotherapy, GBM often recurs due to its invasive nature and resistance to treatment. Management of recurrent GBM poses significant challenges....
-
Product Insights
NewTay-Sachs Disease – Drugs In Development, 2024
Empower your strategies with our Tay-Sachs Disease – Drugs In Development, 2024 report and make more profitable business decisions. Tay-Sachs disease is a rare, inherited metabolic disease that mostly affects young children and involves progressive damage to and death of cells, particularly in the brain. It is caused by a mutation in the enzyme hexosaminidase A, which allows the harmful buildup of lipids (fatty materials such as oils and acids) in cells. Both parents must carry the mutated gene in order...
-
Product Insights
NewHand, Foot and Mouth Disease – Drugs In Development, 2024
Empower your strategies with our Hand, Foot and Mouth Disease – Drugs In Development, 2024 report and make more profitable business decisions. Hand, foot and mouth disease (HFMD) is an illness that causes sores in or on the mouth and on the hands, feet, and legs. Hand, foot and mouth disease is most commonly caused by coxsackievirus A16, a member of the enterovirus family. Symptoms include fever, headache, loss of appetite, and ulcers in the throat (including tonsils), mouth, and tongue....
-
Product Insights
NewTrigeminal Neuralgia (Tic Douloureux) – Drugs In Development, 2024
Empower your strategies with our Trigeminal Neuralgia (Tic Douloureux) – Drugs In Development, 2024 report and make more profitable business decisions. Trigeminal neuralgia is a chronic pain condition that affects the trigeminal nerve, which carries sensation from the face to the brain. Symptoms include spontaneous attacks of pain or attacks triggered by things such as touching the face, chewing, speaking, and brushing teeth; pain in areas supplied by the trigeminal nerve, including the cheek, jaw, teeth, gums, lips, or less often...
-
Product Insights
NewGloboid Cell Leukodystrophy (Krabbe Disease) – Drugs In Development, 2024
Empower your strategies with our Globoid Cell Leukodystrophy (Krabbe Disease) – Drugs In Development, 2024 report and make more profitable business decisions. Krabbe disease, also called globoid cell leukodystrophy, is a degenerative disorder caused by a deficiency of an enzyme called galactosylceramidase. This enzyme deficiency impairs the growth and maintenance of myelin. Symptoms include seizures, muscle spasms, loss of head control, vomiting, fever, irritability, and excessive crying. Risk factors include family history. Treatment focuses on managing symptoms (anticonvulsants, muscle relaxers) and...